Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gunn

Showing results (201-210 of 216) with videos related to

Pageof 22
Sort By:
Brain Communications|April 6, 2023
A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimodAndreas-Antonios Roussakis, Marta Gennaro, Mark Forrest Gordon, et al.
Molecular Psychiatry|February 7, 2022
Relationship between astrocyte reactivity, using novel <sup>11</sup>C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individualsNicholas R Livingston, Valeria Calsolaro, Rainer Hinz, et al.
Biological Psychiatry|January 12, 2023
Brain Serotonin Release Is Reduced in Patients With Depression: A [<sup>11</sup>C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine ChallengeDavid Erritzoe, Beata R Godlewska, Gaia Rizzo, et al.
Biological Psychiatry|March 6, 2012
Endogenous opioid release in the human brain reward system induced by acute amphetamine administrationAlessandro Colasanti, Graham E Searle, Christopher J Long, et al.
Science Translational Medicine|August 17, 2022
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's diseaseAshwin V Venkataraman, Ayla Mansur, Gaia Rizzo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2015
Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological GamblersInge Mick, Jim Myers, Anna C Ramos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's diseaseWilliam Kielbasa, Paul Goldsmith, Kevin B Donnelly, et al.
Brain Communications|November 9, 2022
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerabilityBryan Ng, Helen A Rowland, Tina Wei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 31, 2025
Evaluation of Mitochondrial Complex 1 Density with [<sup>18</sup>F]BCPP-EF in a Murine Model and Individuals with Friedreich AtaxiaLaigao Chen, Gaia Rizzo, Christine Bulawa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2017
Quantification of Lung PET Images: Challenges and OpportunitiesDelphine L Chen, Joseph Cheriyan, Edwin R Chilvers, et al.
Pageof 22

Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Brain Communications|April 6, 2023
A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimodAndreas-Antonios Roussakis, Marta Gennaro, Mark Forrest Gordon, et al.
Molecular Psychiatry|February 7, 2022
Relationship between astrocyte reactivity, using novel <sup>11</sup>C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individualsNicholas R Livingston, Valeria Calsolaro, Rainer Hinz, et al.
Biological Psychiatry|January 12, 2023
Brain Serotonin Release Is Reduced in Patients With Depression: A [<sup>11</sup>C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine ChallengeDavid Erritzoe, Beata R Godlewska, Gaia Rizzo, et al.
Biological Psychiatry|March 6, 2012
Endogenous opioid release in the human brain reward system induced by acute amphetamine administrationAlessandro Colasanti, Graham E Searle, Christopher J Long, et al.
Science Translational Medicine|August 17, 2022
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's diseaseAshwin V Venkataraman, Ayla Mansur, Gaia Rizzo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2015
Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological GamblersInge Mick, Jim Myers, Anna C Ramos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's diseaseWilliam Kielbasa, Paul Goldsmith, Kevin B Donnelly, et al.
Brain Communications|November 9, 2022
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerabilityBryan Ng, Helen A Rowland, Tina Wei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 31, 2025
Evaluation of Mitochondrial Complex 1 Density with [<sup>18</sup>F]BCPP-EF in a Murine Model and Individuals with Friedreich AtaxiaLaigao Chen, Gaia Rizzo, Christine Bulawa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2017
Quantification of Lung PET Images: Challenges and OpportunitiesDelphine L Chen, Joseph Cheriyan, Edwin R Chilvers, et al.
Pageof 22